Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Market Cap	58Cr 173.7Cr 50Cr 47Cr 43Cr 80Cr 5.46TCr 80Cr 551.73Cr 214.87Cr 2.79TCr 216.92Cr 212.19Cr 8.99TCr	P/E 2026 *	-	P/E 2027 *	-
Enterprise Value	58Cr 173.7Cr 50Cr 47Cr 43Cr 80Cr 5.46TCr 80Cr 551.73Cr 214.87Cr 2.79TCr 216.92Cr 212.19Cr 8.99TCr	EV / Sales 2026 *	8.35x	EV / Sales 2027 *	6.77x
Free-Float	90.5%	Yield 2026 *	-	Yield 2027 *	-

01/09	Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO	MT
27/08	BrainsWay Ltd. Publishes Peer-Reviewed Data Demonstrating 70% Reduction in Suicidal Ideation with Deep TMS in Major Depressive Disorder	CI
13/08	BrainsWay Shares Rise After Higher Q2 Results	MT
12/08	BrainsWay Ltd., Q2 2026 Earnings Call, Aug 12, 2026
12/08	BrainsWay Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
12/08	BrainsWay Ltd. Raises Earnings Guidance for the Fiscal Year 2026	CI
20/07	Radial Health, S.C. announced that it has received $53 million in funding from a group of investors	CI
20/07	BTIG Initiates Brainsway at Buy With $18 Price Target	MT
16/07	Sound Minds Behavioral announced that it expects to receive $0.5 million in funding from BrainsWay Ltd.	CI
16/07	BrainsWay Announces Strategic Investment in Sound Minds Behavioral	MT
29/06	Brainsway Ltd. Presents Positive Data From Largest Real-World Study Of Deep TMS In Patients With Comorbid PTSD And Major Depressive Disorder	CI
09/06	BrainsWay Presents First SWIFT Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting	CI
18/05	Hopemark Health, Ltd announced that it expects to receive funding from BrainsWay Ltd.	CI

20/07	BTIG Initiates Brainsway at Buy With $18 Price Target	MT
13/11	BrainsWay Ltd. Receives FDA Clearance of Deep TMS as Adjunct Therapy for Major Depressive Disorder in Adolescents Aged 15 to 21	CI
14/25/14	Oppenheimer Adjusts Brainsway Price Target to $15 From $13, Maintains Outperform Rating	MT
09/24/09	Oppenheimer Adjusts Brainsway Price Target to $11 From $10, Maintains Outperform Rating	MT
09/24/09	HC Wainwright Adjusts Price Target on Brainsway to $15 From $13, Keeps Buy Rating	MT

27/08	BrainsWay Deep TMS™ Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation	AQ
12/08	BrainsWay Reports Second Quarter 2026 Financial Results and Operational Highlights	AQ
29/07	BrainsWay to Report Second Quarter 2026 Financial Results on August 12, 2026	AQ
20/07	BrainsWay Announces Strategic Investment in Radial Health, Inc.	AQ
16/07	BrainsWay Announces Minority-Stake Investment in Sound Minds Behavioral	AQ

Manager	Title	Age	Since
Hadar Levy CEO	Chief Executive Officer	54	13/02/2023
Yiftach Roth CTO	Chief Tech/Sci/R&D Officer	56	01/05/2006
Ido Marom DFI	Director of Finance/CFO	50	23/05/2023

BrainsWay Ltd. Share Price TEL AVIV STOCK EXCHANGE

Stocks

BWAY

IL0011007189

Advanced Medical Equipment & Technology

Valuation : BrainsWay Ltd.

Latest news : BrainsWay Ltd.

Last Transcript : BrainsWay Ltd.

Analysts' recommendations : BrainsWay Ltd.

Press Releases : BrainsWay Ltd.

Quotes and Performance

Managers and Directors : BrainsWay Ltd.

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Director	Title	Age	Since
David Zacut CHM	Chairman	74	01/01/2003
Avner Hagai BRD	Director/Board Member	70	01/11/2006
Abraham Zangen BRD	Director/Board Member	56	17/06/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BRAINSWAY LTD.	+10.37%	+15.65%	-	-	58Cr
THERMO FISHER SCIENTIFIC, INC.	-0.77%	-1.65%	+25.01%	+12.90%	23TCr
DANAHER CORPORATION	-1.70%	-4.29%	+3.90%	-20.72%	15TCr
INTUITIVE SURGICAL, INC.	-1.42%	-2.08%	-19.73%	+18.58%	13TCr
BOSTON SCIENTIFIC CORPORATION	+1.67%	+1.76%	-55.57%	-10.57%	6.8TCr
EDWARDS LIFESCIENCES CORPORATION	-0.13%	-0.60%	+10.76%	+18.03%	5.17TCr
SIEMENS HEALTHINEERS AG	+0.52%	-1.11%	-17.10%	-14.24%	5.02TCr
AGILENT TECHNOLOGIES, INC.	+0.56%	-2.09%	+17.23%	+26.86%	4.23TCr
WATERS CORPORATION	-1.07%	-1.63%	+36.11%	+47.61%	4.06TCr
RESMED, INC.	-0.87%	-5.57%	-17.12%	+47.47%	3.31TCr
Average	+0.72%	-1.35%	-1.83%	+13.99%	8.82TCr
Weighted average by Cap.	-0.66%	-1.78%	+1.60%	+8.12%

	2026 *	2027 *
Net sales	6.92Cr 21Cr 5.95Cr 5.58Cr 5.11Cr 9.54Cr 653.77Cr 9.61Cr 66Cr 26Cr 334.1Cr 26Cr 25Cr 1.08TCr	8.53Cr 26Cr 7.34Cr 6.89Cr 6.3Cr 12Cr 806.67Cr 12Cr 82Cr 32Cr 412.24Cr 32Cr 31Cr 1.33TCr
Net income	1.24Cr 3.72Cr 1.07Cr 99.99L 91.48L 1.71Cr 117.06Cr 1.72Cr 12Cr 4.61Cr 60Cr 4.65Cr 4.55Cr 192.67Cr	2.1Cr 6.3Cr 1.8Cr 1.69Cr 1.55Cr 2.89Cr 198.18Cr 2.91Cr 20Cr 7.8Cr 101.28Cr 7.87Cr 7.7Cr 326.17Cr
Net Debt	-	-